Estrogen Impact on Autoimmunity Onset and Progression: the ...

More documents

Recommendations

Info

INTERNATIONAL TRENDS IN IMMUNITY VOL.1 NO.2 APRIL 2013ISSN 2326-3121 (Print) ISSN 2326-313X (Online) http://www.researchpub.org/journal/iti/iti.html[49] Liang D, and Shen N: MicroRNA involvement in lupus:the beginning of a new tale. Curr Opin Rheumatol, 24, 489-98,2012.[50] Dai R, and Ahmed SA: MicroRNA, a new paradigm forunderstanding immunoregulation, inflammation, andautoimmune diseases. Transl Res, 157, 163-79, 2011.[51] Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y, Huang X,Zhou H, de Vries N, Tak PP, Chen S, and Shen N:MicroRNA-146A contributes to abnormal activation of the typeI interferon pathway in human lupus by targeting the keysignaling proteins. Arthritis Rheum, 60, 1065-75, 2009.[52] Zhao X, Tang Y, Qu B, Cui H, Wang S, Wang L, Luo X,Huang X, Li J, Chen S, and Shen N: MicroRNA-125acontributes to elevated inflammatory chemokine RANTESlevels via targeting KLF13 in systemic lupus erythematosus.Arthritis Rheum, 62, 3425-35, 2010.[53] Zhang Y, Zhao M, Sawalha AH, Richardson B, and Lu Q:Impaired DNA methylation and its mechanisms in CD4(+)Tcells of systemic lupus erythematosus. J Autoimmun, 2013.[54] Pan W, Zhu S, Yuan M, Cui H, Wang L, Luo X, Li J, ZhouH, Tang Y, and Shen N: MicroRNA-21 and microRNA-148acontribute to DNA hypomethylation in lupus CD4+ T cells bydirectly and indirectly targeting DNA methyltransferase 1. JImmunol, 184, 6773-81, 2010.[55] Dai R, Phillips RA, Zhang Y, Khan D, Crasta O, andAhmed SA: Suppression of LPS-induced Interferon-gammaand nitric oxide in splenic lymphocytes by selectestrogen-regulated microRNAs: a novel mechanism of immunemodulation. Blood, 112, 4591-7, 2008.[56] Liu ZH, Cheng ZH, Gong RJ, Liu H, Liu D, and Li LS: Sexdifferences in estrogen receptor gene polymorphism and itsassociation with lupus nephritis in Chinese. Nephron, 90,174-80, 2002.[57] Lee YJ, Shin KS, Kang SW, Lee CK, Yoo B, Cha HS, KohEM, Yoon SJ, and Lee J: Association of the oestrogen receptoralpha gene polymorphisms with disease onset in systemic lupuserythematosus. Ann Rheum Dis, 63, 1244-9, 2004.[58] Johansson M, Arlestig L, Moller B, Smedby T, andRantapaa-Dahlqvist S: Oestrogen receptor {alpha} genepolymorphisms in systemic lupus erythematosus. Ann RheumDis, 64, 1611-7, 2005.[59] Kisiel BM, Kosinska J, Wierzbowska M, Rutkowska-SakL, Musiej-Nowakowska E, Wudarski M, Olesinska M,Krajewski P, Lacki J, Rell-Bakalarska M, Jagodzinski PP,Tlustochowicz W, and Ploski R: Differential association ofjuvenile and adult systemic lupus erythematosus with geneticvariants of oestrogen receptors alpha and beta. Lupus, 20, 85-9,2011.[60] Harley JB, Alarcon-Riquelme ME, Criswell LA, Jacob CO,Kimberly RP, Moser KL, Tsao BP, Vyse TJ, Langefeld CD,Nath SK, Guthridge JM, Cobb BL, Mirel DB, Marion MC,Williams AH, Divers J, Wang W, Frank SG, Namjou B, GabrielSB, Lee AT, Gregersen PK, Behrens TW, Taylor KE, FernandoM, Zidovetzki R, Gaffney PM, Edberg JC, Rioux JD, OjwangJO, James JA, Merrill JT, Gilkeson GS, Seldin MF, Yin H,Baechler EC, Li QZ, Wakeland EK, Bruner GR, Kaufman KM,and Kelly JA: Genome-wide association scan in women withsystemic lupus erythematosus identifies susceptibility variants33in ITGAM, PXK, KIAA1542 and other loci. Nat Genet, 40,204-10, 2008.[61] Hom G, Graham RR, Modrek B, Taylor KE, Ortmann W,Garnier S, Lee AT, Chung SA, Ferreira RC, Pant PV, BallingerDG, Kosoy R, Demirci FY, Kamboh MI, Kao AH, Tian C,Gunnarsson I, Bengtsson AA, Rantapaa-Dahlqvist S, Petri M,Manzi S, Seldin MF, Ronnblom L, Syvanen AC, Criswell LA,Gregersen PK, and Behrens TW: Association of systemic lupuserythematosus with C8orf13-BLK and ITGAM-ITGAX. NEngl J Med, 358, 900-9, 2008.[62] Roubinian JR, Talal N, Greenspan JS, Goodman JR, andSiiteri PK: Effect of castration and sex hormone treatment onsurvival, anti-nucleic acid antibodies, and glomerulonephritis inNZB/NZW F1 mice. J Exp Med, 147, 1568-83, 1978.[63] Li J, and McMurray RW: Effects of estrogen receptorsubtype-selective agonists on autoimmune disease inlupus-prone NZB/NZW F1 mouse model. Clin Immunol, 123,219-26, 2007.[64] Svenson JL, EuDaly J, Ruiz P, Korach KS, and GilkesonGS: <strong>Impact</strong> of estrogen receptor deficiency on diseaseexpression in the NZM2410 lupus prone mouse. Clin Immunol,128, 259-68, 2008.[65] Cunningham MA, Naga OS, Eudaly JG, Scott JL, andGilkeson GS: <strong>Estrogen</strong> receptor alpha modulates Toll-likereceptor signaling in murine lupus. Clin Immunol, 144, 1-12,2012.[66] Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, JacobsDR, Jr., Lee DH, Shioda T, Soto AM, vom Saal FS, WelshonsWV, Zoeller RT, and Myers JP: Hormones andendocrine-disrupting chemicals: low-dose effects andnonmonotonic dose responses. Endocr Rev, 33, 378-455, 2012.[67] Chighizola C, and Meroni PL: The role of environmentalestrogens and autoimmunity. Autoimmun Rev, 11, A493-501,2012.[68] Franke AA, Custer LJ, Cerna CM, and Narala K: RapidHPLC analysis of dietary phytoestrogens from legumes andfrom human urine. Proc Soc Exp Biol Med, 208, 18-26, 1995.[69] Katzenellenbogen BS, Katzenellenbogen JA, andMordecai D: Zearalenones: characterization of the estrogenicpotencies and receptor interactions of a series of fungalbeta-resorcylic acid lactones. Endocrinology, 105, 33-40, 1979.[70] Schug TT, Janesick A, Blumberg B, and Heindel JJ:Endocrine disrupting chemicals and disease susceptibility. JSteroid Biochem Mol Biol, 127, 204-15, 2011.[71] Ahmed SA: The immune system as a potential target forenvironmental estrogens (endocrine disrupters): a newemerging field. Toxicology, 150, 191-206, 2000.[72] Rogers JA, Metz L, and Yong VW: Review: Endocrinedisrupting chemicals and immune responses: A focus onbisphenol-A and its potential mechanisms. Mol Immunol, 53,421-30, 2013.[73] Delfosse V, Grimaldi M, Pons JL, Boulahtouf A, le MaireA, Cavailles V, Labesse G, Bourguet W, and Balaguer P:Structural and mechanistic insights into bisphenols actionprovide guidelines for risk assessment and discovery ofbisphenol A substitutes. Proc Natl Acad Sci U S A, 109,14930-5, 2013.[74] Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH,van der Saag PT, van der Burg B, and Gustafsson JA:
INTERNATIONAL TRENDS IN IMMUNITY VOL.1 NO.2 APRIL 2013ISSN 2326-3121 (Print) ISSN 2326-313X (Online) http://www.researchpub.org/journal/iti/iti.htmlInteraction of estrogenic chemicals and phytoestrogens withestrogen receptor beta. Endocrinology, 139, 4252-63, 1998.[75] Hiroi H, Tsutsumi O, Momoeda M, Takai Y, Osuga Y, andTaketani Y: Differential interactions of bisphenol A and17beta-estradiol with estrogen receptor alpha (ERalpha) andERbeta. Endocr J, 46, 773-8, 1999.[76] Sawai C, Anderson K, and Walser-Kuntz D: Effect ofbisphenol A on murine immune function: modulation ofinterferon-gamma, IgG2a, and disease symptoms in NZB XNZW F1 mice. Environ Health Perspect, 111, 1883-7, 2003.[77] Yurino H, Ishikawa S, Sato T, Akadegawa K, Ito T, Ueha S,Inadera H, and Matsushima K: Endocrine disruptors(environmental estrogens) enhance autoantibody production byB1 cells. Toxicol Sci, 81, 139-47, 2004.[78] Sobel ES, Gianini J, Butfiloski EJ, Croker BP,Schiffenbauer J, and Roberts SM: Acceleration ofautoimmunity by organochlorine pesticides in (NZB x NZW)F1mice. Environ Health Perspect, 113, 323-8, 2005.[79] Li J, and McMurray RW: Effects of chronic exposure toDDT and TCDD on disease activity in murine systemic lupuserythematosus. Lupus, 18, 941-9, 2009.[80] Lee TP, and Chiang BL: Sex differences in spontaneousversus induced animal models of autoimmunity. AutoimmunRev, 11, A422-9, 2012.[81] Cooke PS, Selvaraj V, and Yellayi S: Genistein, estrogenreceptors, and the acquired immune response. J Nutr, 136,704-8, 2006.[82] Polkowski K, and Mazurek AP: Biological properties ofgenistein. A review of in vitro and in vivo data. Acta Pol Pharm,57, 135-55, 2000.[83] Zhao JH, Sun SJ, Horiguchi H, Arao Y, Kanamori N,Kikuchi A, Oguma E, and Kayama F: A soy diet acceleratesrenal damage in autoimmune MRL/Mp-lpr/lpr mice. IntImmunopharmacol, 5, 1601-10, 2005.[84] Hong Y, Wang T, Huang C, Cheng W, and Lin B: Soyisoflavones supplementation alleviates disease severity inautoimmune-prone MRL-lpr/lpr mice. Lupus, 17, 814-21,2008.[85] Hong YH, Huang CJ, Wang SC, and Lin BF: The ethylacetate extract of alfalfa sprout ameliorates disease severity ofautoimmune-prone MRL-lpr/lpr mice. Lupus, 18, 206-15,2009.[86] Schoenroth LJ, Hart DA, Pollard KM, and Fritzler MJ: Theeffect of the phytoestrogen coumestrol on the NZB/W F1murine model of systemic lupus. J Autoimmun, 23, 323-32,2004.[87] Wingard DL, and Turiel J: Long-term effects of exposureto diethylstilbestrol. West J Med, 149, 551-4, 1988.[88] Noller KL, Blair PB, O'Brien PC, Melton LJ, 3rd, OffordJR, Kaufman RH, and Colton T: Increased occurrence ofautoimmune disease among women exposed in utero todiethylstilbestrol. Fertil Steril, 49, 1080-2, 1988.[89] Forsberg JG: Neonatal estrogen treatment and itsconsequences for thymus development, serum level ofautoantibodies to cardiolipin, and the delayed-typehypersensitivity response. J Toxicol Environ Health A, 60,185-213, 2000.[90] Lateef A, and Petri M: Hormone replacement andcontraceptive therapy in autoimmune diseases. J Autoimmun,38, J170-6, 2012.[91] Buyon JP, Petri MA, Kim MY, Kalunian KC, Grossman J,Hahn BH, Merrill JT, Sammaritano L, Lockshin M, Alarcon GS,Manzi S, Belmont HM, Askanase AD, Sigler L, Dooley MA,Von Feldt J, McCune WJ, Friedman A, Wachs J, Cronin M,Hearth-Holmes M, Tan M, and Licciardi F: The effect ofcombined estrogen and progesterone hormone replacementtherapy on disease activity in systemic lupus erythematosus: arandomized trial. Ann Intern Med, 142, 953-62, 2005.[92] Silva CP, Otero M, and Esteves V: Processes for theelimination of estrogenic steroid hormones from water: areview. Environ Pollut, 165, 38-58, 2012.[93] Yin GG, Kookana RS, and Ru YJ: Occurrence and fate ofhormone steroids in the environment. Environ Int, 28, 545-51,2002.[94] Kelly RH, and Vertosick FT, Jr.: Systemic lupuserythematosus: a role for anti-receptor antibodies? MedHypotheses, 20, 95-101, 1986.[95] Colasanti T, Maselli A, Conti F, Sanchez M, Alessandri C,Barbati C, Vacirca D, Tinari A, Chiarotti F, Giovannetti A,Franconi F, Valesini G, Malorni W, Pierdominici M, andOrtona E: Autoantibodies to estrogen receptor alpha interferewith T lymphocyte homeostasis and are associated with diseaseactivity in systemic lupus erythematosus. Arthritis Rheum, 64,778-87, 2011.[96] Gaipl US, Kuhn A, Sheriff A, Munoz LE, Franz S, Voll RE,Kalden JR, and Herrmann M: Clearance of apoptotic cells inhuman SLE. Curr Dir Autoimmun, 9, 173-87, 2006.[97] Grossmayer GE, Munoz LE, Gaipl US, Franz S, Sheriff A,Voll RE, Kalden JR, and Herrmann M: Removal of dying cellsand systemic lupus erythematosus. Mod Rheumatol, 15,383-90, 2005.[98] Wakeland EK, Liu K, Graham RR, and Behrens TW:Delineating the genetic basis of systemic lupus erythematosus.Immunity, 15, 397-408, 2001.34
Page 1 and 2: INTERNATIONAL TRENDS IN IMMUNITY VO
Page 9: INTERNATIONAL TRENDS IN IMMUNITY VO

Estrogen Impact on Autoimmunity Onset and Progression: the ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?